Connect with us

News

US colleges and universities have billions stashed away in endowments − a higher ed finance expert explains what they are

Published

on

US colleges
Prospective students tour Georgetown University’s campus in Washington in 2013. AP Photo/Jacquelyn Martin
Todd L. Ely, University of Colorado Denver With the Trump administration seeking to cut federal funding for colleges and universities, you might be wondering whether the endowments of these institutions of higher education might be able to fill those gaps. Todd L. Ely, a professor of public administration at the University of Colorado Denver, explains what endowments are and the constraints placed on them.

What’s an endowment?

Endowments are pools of financial investments that belong to a nonprofit. These assets produce a revenue stream, typically from dividends, interest and realized capital gains. The funds endowments hold usually originate as charitable donations made to support an institution’s mission. In most cases with higher education endowments, this wealth, which helps buoy a nonprofit’s budget, is supposed to last forever. Contributions to endowments are tax-deductible for donors who itemize their tax returns. Once these funds are invested, they grow generally tax-free. But beginning in 2018, the federal government imposed a 1.4% excise tax on dozens of higher education institutions with relatively large endowments. Few colleges or universities have a single endowment fund. That’s because the donors who provide gifts large and small to the school over the years direct their donations to different funds reserved for specific purposes. Harvard University’s endowment, worth $53.2 billion at the end of its 2024 fiscal year, for example, consists of roughly 14,600 distinct funds. All told, money distributed from endowments covered more than 15%, on average, of college and university operating expenses in 2024. Some of America’s institutions of higher education, however, lean much more heavily than that on their endowments to pay their bills.
People walk past a Trojan statue.
People pose for photos in front of the iconic Tommy Trojan statue on the campus of the University of Southern California in Los Angeles in 2019. AP Photo/Reed Saxon

How do endowments influence higher education?

Endowments can serve multiple purposes. In 2024, nearly half of all higher education spending paid for with endowment revenue funded scholarships and other kinds of aid for students, while almost 18% supported academic programs. Just under 11% paid for professors’ compensation, and almost 7% helped pay for running and maintaining campus facilities. More broadly, endowments can help shield schools from financial hardships and maintain their long-term reputations. When they’re set up to carry on in perpetuity, endowments must benefit both current and future generations. So when donors give to an endowment, they are arguably investing in the long-term viability of the institution. This long-term focus suggests that endowments aren’t just rainy-day funds or financial reserves.

Why can’t endowment funds be spent freely?

At the end of the 2023 fiscal year, U.S. higher education endowments held a total of more than $907 billion. That is a lot of money, but it’s still less than the combined wealth of America’s five richest people. Like individual wealth, endowment assets are heavily concentrated in the U.S. Many colleges and universities have small or no endowments. Nearly 60% of them total less than $50 million. The top 25, which includes several public universities in states such as Michigan and Texas, account for more than half of all endowment assets. And even when schools have large endowments, the individual funds that compose them are bound by a wide array of restrictions. Some of that money can be spent however the school would like. Other funds are dedicated to a clearly defined purpose. When endowment funds are restricted, the school gets little discretion in how to spend them. At Harvard, for example, there’s a Hollis Professorship of Divinity at Harvard University. It was established in 1721 through a gift from a London merchant. Based on the terms of that long-ago donation, the earnings and growth of the donated funds continue to honor the donor’s intent by supporting the position, regardless of what the university needs. Alternatively, endowments may receive donations that are temporarily restricted. Known as “term” endowments, the assets they hold can be used once donor-imposed conditions are fulfilled. Institutions frequently designate some of their unrestricted funds as “quasi” endowments, usually earmarked for specific strategic purposes. This board-designated quasi-endowment does not carry legal restrictions and can be spent more freely. About 40% of higher education endowment assets are subject to permanent restrictions, 30% are temporarily restricted, and 29% are reserved for quasi-endowment use.
Young people walk past a modern building.
People walk past the Ray and Maria Stata Center on the campus of the Massachusetts Institute of Technology in 2019. AP Photo/Steven Senne

How are decisions over endowment funds made?

The decision-making authority over endowments typically rests with a college or university’s governing board. Those boards establish endowment payout policies that guide how much of the endowment and its earnings can be spent each year, while attempting to preserve the purchasing power of the investments over the long term. The policies take expectations regarding investment earnings and inflation into account, while smoothing annual payouts by using a percentage of the value of the endowment over multiple years as opposed to a single point in time. This payout tends to amount to about 5% of all assets. That share averaged 4.8% in 2024. U.S. institutions of higher education spent nearly $35.5 billion derived from their endowments in the 2023 fiscal year. Colleges and universities that depend more heavily on their endowment funds to cover their current obligations may choose to invest more conservatively. In recent years, many higher education endowments have obtained more complex investments, such as private equity, real assets and stakes in hedge funds. Endowments of nonprofit colleges and universities are also governed in most states by a state law known as the Uniform Prudent Management of Institutional Funds Act. This law encourages cautious investments and restrained spending. These restrictions mean that annual payouts are generally modest. That leaves endowments ill-equipped to respond to abrupt and large shifts in their funding needs. The John F. Kennedy School of Government, commonly referred to as Harvard Kennedy School, is a member of The Conversation U.S.The Conversation Todd L. Ely, Associate Professor of Public Administration; Director, Center for Local Government, University of Colorado Denver This article is republished from The Conversation under a Creative Commons license. Read the original article.

Discover more from Daily News

Subscribe to get the latest posts sent to your email.

Continue Reading
Advertisement SodaStream USA, inc

News

RFK Jr. says annual COVID-19 shots no longer advised for healthy children and pregnant women – a public health expert explains the new guidance

Published

on

file 20250528 56 tbtzj3.jpg?ixlib=rb 4.1
Until now, the CDC has recommended that everyone ages 6 months and older get a yearly COVID-19 vaccine. Asiaselects via Getty Images
Libby Richards, Purdue University On May 27, 2025, Health and Human Services Secretary Robert F. Kennedy Jr. announced that the Centers for Disease Control and Prevention will no longer include the COVID-19 vaccine on the list of immunizations it recommends for healthy children and pregnant women. The announcement, made in a video posted on the social platform X, comes on the heels of another announcement, made on May 20, in which the Food and Drug Administration revealed that it will approve new versions of the vaccine only for adults 65 years of age and older and for people with one or more risk factors for severe COVID-19 outcomes. The agency will require vaccine manufacturers to conduct clinical trials to demonstrate that the vaccine benefits low-risk groups. The Conversation U.S. asked Libby Richards, a nursing professor from Purdue University involved in public health promotion, to explain what these announcements mean for the general public.

Why are HHS and FDA diverging from past practice?

Currently, getting a yearly COVID-19 vaccine is recommended for everyone ages 6 months and older, regardless of their health risk. In the video announcing the plan to remove the vaccine from the CDC’s recommended immunization schedule for healthy children and healthy pregnant women, Kennedy spoke alongside National Institutes of Health Director Jay Bhattacharya and FDA Commissioner Marty Makary. The trio cited a lack of evidence to support vaccinating healthy children. They did not explain the reason for the change to the vaccine schedule for pregnant people, who have previously been considered at high-risk for severe COVID-19. Similarly, in the FDA announcement made a week prior, Makary and the agency’s head of vaccines, Vinay Prasad, said that public health trends now support limiting vaccines to people at high risk of serious illness instead of a universal COVID-19 vaccination strategy.

Was this a controversial decision or a clear consensus?

Many public health experts and professional health care associations have raised concerns about Kennedy’s latest announcement, saying it contradicts studies showing that COVID-19 vaccination benefits pregnant people and children. The American College of Obstetrics and Gynecology, considered the premier professional organization for that medical specialty, reinforced the importance of COVID-19 vaccination during pregnancy, especially to protect infants after birth. Likewise, the American Academy of Pediatrics pointed to the data on hospitalizations of children with COVID-19 during the 2024-to-2025 respiratory virus season as evidence for the importance of vaccination. Kennedy’s announcement on children and pregnant women comes roughly a month ahead of a planned meeting of the Advisory Committee on Immunization Practices, a panel of vaccine experts that offers guidance to the CDC on vaccine policy. The meeting was set to review guidance for the 2025-to-2026 COVID-19 vaccines. It’s not typical for the CDC to alter its recommendations without input from the committee.
Robert F. Kennedy Jr. has removed COVID-19 vaccines from the vaccine schedule for healthy children and pregnant people.
FDA officials Makary and Prasad also strayed from past established vaccine regulatory processes in announcing the FDA’s new stance on recommendations for healthy people under age 65. Usually, the FDA broadly approves a vaccine based on whether it is safe and effective, and decisions on who should be eligible to receive it are left to the CDC, which bases its decision on the advisory committee’s research-based guidance. The advisory committee was expected to recommend a risk-based approach for the COVID-19 vaccine, but it was also expected to recommend allowing low-risk people to get annual COVID-19 vaccines if they want to. The CDC’s and FDA’s new policies on the vaccine will likely make it difficult for healthy people to get the vaccine.

What conditions count as risk factors?

The CDC lists several medical conditions and other factors that increase peoples’ risk for severe COVID-19. These conditions include cancer, diabetes, heart disease, obesity, chronic kidney disease and some lung conditions like COPD and asthma. Pregnancy is also on the list. The article authored by Makary and Prasad describing the FDA’s new stance on the vaccine also contain a lengthy list of risk factors and notes that about 100 million to 200 million people will fall into this category and will thus be eligible to get the vaccine. Pregnancy is included. Reversing the recommendation for vaccinating healthy pregnant women thus contradicts the new framework described by the FDA. Studies have documented that COVID-19 vaccines are safe during pregnancy and may reduce the risk of stillbirth. A study published in May 2025 using data from 26,783 pregnancies found a link between COVID-19 infection before and during pregnancy and an increased risk for spontaneous abortions. Importantly, a 2024 analysis of 120 studies including a total of 168,444 pregnant women with COVID-19 infections did not find enough evidence to suggest the infections are a direct cause of early pregnancy loss. Nonetheless, the authors did state that COVID-19 vaccination remains a crucial preventive measure for pregnant women to reduce the overall risk of serious complications in pregnancy due to infection. Immune changes during pregnancy increase the risk of severe illness from respiratory viruses. Vaccination during pregnancy also provides protection to the fetus that lasts into the first few months of life and is associated with a lower risk of COVID-19 related hospitalization among infants.
Rite-Aid sign advertising COVID-19 vaccines
Change is coming to COVID-19 vaccine policy. Rick Obst, CC BY-SA
The changes to the CDC’s and the FDA’s plan for COVID-19 vaccines also leave out an important group – caregivers and household members of people at high risk of severe illness from infection. This omission leaves high-risk people more vulnerable to exposure to COVID-19 from healthy people they regularly interact with. Multiple countries with risk-based vaccination policies do include this group.

What about vaccines for children?

High-risk children age 6 months and older who have conditions that increase the risk of severe COVID-19 are still eligible for the vaccine. Existing vaccines already on the market will remain available, but it is unclear how long they will stay authorized and how the change in vaccine policy will affect childhood vaccination overall. To date, millions of children have safely received the COVID-19 vaccine. Data on whether children benefit from annual COVD-19 vaccines is less clear. Parents and clinicians make vaccination decisions by weighing potential risks with potential benefits.

Will low-risk people be able to get a COVID-19 shot?

Not automatically. Kennedy’s announcement does not broadly address healthy adults, but under the new FDA framework, healthy adults who wish to receive the fall COVID-19 vaccine will likely face obstacles. Health care providers can administer vaccines “off-label”, but insurance coverage is widely based on FDA recommendations. The new, narrower FDA approval will likely reduce both access to COVID-19 vaccines for the general public and insurance coverage for COVID-19 vaccines. Under the Affordable Care Act, Medicare, Medicaid and private insurance providers are required to fully cover the cost of any vaccine endorsed by the CDC. Kennedy’s announcement will likely limit insurance coverage for COVID-19 vaccination. Overall, the move to focus on individual risks and benefits may overlook broader public health benefits. Communities with higher vaccination rates have fewer opportunities to spread the virus. This is an updated version of an article originally published on May 22, 2025. Libby Richards, Professor of Nursing, Purdue University This article is republished from The Conversation under a Creative Commons license. Read the original article.

Discover more from Daily News

Subscribe to get the latest posts sent to your email.

Continue Reading

Automotive

The 2026 Nissan LEAF Debuts: A Bold New Era for Affordable EVs

Published

on

2026 Nissan LEAF

Nissan unveils all-new third-generation LEAF

The All-New 2026 Nissan LEAF Is Here — Sleek, Smart, and Ready to Lead

Nissan has officially lifted the curtain on the all-new 2026 LEAF, and it’s not just an update—it’s a total reinvention. The third-generation LEAF blends sleek, aerodynamic styling with SUV-like proportions, signaling a bold departure from the hatchback form that defined the nameplate for over a decade. This refreshed design marks a new chapter for one of the world’s most accessible and best-selling electric vehicles.

With nearly 700,000 global sales under its belt, the LEAF has long been a pioneer in the mass-market EV space. The 2026 model takes that foundation and builds upon it in every direction—design, technology, comfort, and capability. Whether you’re a loyal EV enthusiast or making the switch from a gas-powered car, Nissan’s newest electric offering is designed to meet you where you are and elevate your driving experience.

@stmblog

The all-new 2026 Nissan LEAF is here! Sleek SUV style, longer range, smart tech & faster charging. Arrives this fall. ⚡🚗 #NissanLEAF ♬ original sound – STMDailyNews

Striking Design Meets Everyday Versatility

The all-new LEAF sports clean, sculpted body lines and a wide stance that echoes modern crossover aesthetics. Inside, the cabin is minimal yet inviting, focused on comfort, spaciousness, and wellbeing. A dimming panoramic roof with heat shielding adds a premium touch, while ambient lighting in 64 available colors helps set the perfect mood for any drive.

Performance Meets Practicality

Among the most impressive upgrades is a liquid-cooled lithium-ion battery offering up to 75 kWh of usable capacity—meaning more range, more freedom, and more confidence. Faster charging speeds and the inclusion of the North American Charging Standard (NACS) port with Plug & Charge capability further simplify EV ownership.

Nissan’s all-new 3-in-1 powertrain—a compact, integrated system combining motor, inverter, and reducer—delivers both efficiency and power in a sleek package. It’s an engineering advancement that supports the LEAF’s mission of providing reliable, affordable electric mobility for all.

Tech-Savvy and Feature-Rich

This isn’t just a car—it’s a rolling tech hub. The 2026 LEAF offers dual 14.3-inch displays, wireless Apple CarPlay® and Android Auto™, and Google built-in features like Google Maps. Drivers will enjoy innovative tools like the Invisible Hood View, Front Wide View, and the 3D Intelligent Around View® Monitor—making tight parking and complex driving environments far easier to navigate.

Audiophiles take note: the available Bose® Personal® Plus audio system ensures that your soundtrack is every bit as premium as your ride.

Advertisement
image 101376000 12222003

Built to Impress, Ready for the Road

With details like flush door handles, holographic 3D tail lamps, and available 19-inch wheels, the 2026 LEAF is clearly designed to turn heads. But its mission is practical at heart: making electric driving seamless for everyday users. From its improved range to thoughtful in-cabin tech, Nissan is aiming squarely at the mainstream with this launch.

Assembly for the U.S. and Canadian markets will take place at Nissan’s Tochigi plant in Japan, where the LEAF will be built alongside the Ariya SUV.

The 2026 Nissan LEAF arrives at U.S. dealerships this fall, with availability in other global markets to follow.

Want more 2026 Nissan LEAF details or a feature breakdown?

Stay tuned for a full review once test drives are available—or check out the full press kit for deep specs on every trim level https://usa.nissannews.com/en-US/releases/the-iconic-ev-reimagined-nissan-unveils-all-new-third-generation-leaf

Welcome to the Consumer Corner section of STM Daily News, your ultimate destination for savvy shopping and informed decision-making! Dive into a treasure trove of insights and reviews covering everything from the hottest toys that spark joy in your little ones to the latest electronic gadgets that simplify your life. Explore our comprehensive guides on stylish home furnishings, discover smart tips for buying a home or enhancing your living space with creative improvement ideas, and get the lowdown on the best cars through our detailed auto reviews. Whether you’re making a major purchase or simply seeking inspiration, the Consumer Corner is here to empower you every step of the way—unlock the keys to becoming a smarter consumer today!

https://stmdailynews.com/category/consumer-corner/

Advertisement
image 101376000 12222003

Discover more from Daily News

Subscribe to get the latest posts sent to your email.

Continue Reading

News

Is Residential Solar on the Decline in the U.S.? A Market Correction, Not Collapse

U.S. residential solar installations are declining in 2025. Learn what’s driving the downturn—and why the long-term outlook remains

Published

on

Residential Solar

The once red-hot U.S. residential solar market is showing signs of cooling off—but don’t count it out just yet. A combination of rising interest rates, regulatory changes, and supply chain challenges have led to a notable dip in installations across the country. But while the short-term trend suggests a slowdown, industry experts remain optimistic about the long-term potential of rooftop solar.

📉 The Numbers Don’t Lie: Installations Are Down

According to the Solar Energy Industries Association (SEIA) and Wood Mackenzie, residential solar installations dropped by 13% year-over-year in Q1 2025, with 1,106 megawatts (MW) installed nationwide. That’s also a 4% decline from the previous quarter. This marks a continuation of the trend that began in 2024, which saw the residential sector contract in 22 states—including a five-year low in California [^1].

Analysts at BloombergNEF predict that total U.S. solar capacity will fall by 7% between 2025 and 2027, with a projected 1% annual decline through 2035 under current policy scenarios [^2].

🧾 What’s Behind the Drop?

1. Higher Interest Rates

The Federal Reserve’s continued efforts to tame inflation have made financing solar systems more expensive for homeowners. The result? Fewer consumers are willing to commit to the upfront investment, even with long-term savings in play [^3].

2. Policy Shifts in Key States

California, long considered the leader in solar adoption, rolled back its Net Energy Metering (NEM) 2.0 program in favor of NEM 3.0, which significantly reduces the value of solar exports back to the grid. Installations in the state fell sharply as a result [^1].

On the federal side, proposed cuts to the 30% Investment Tax Credit (ITC)—a major driver of residential adoption—have caused uncertainty in the market. According to Reuters, solar stocks plummeted following changes in a Senate tax bill that threatened to shrink or eliminate these credits [^4].

Advertisement
image 101376000 12222003

3. Tariffs and Supply Constraints

Tariffs on Chinese and other foreign-made solar panels have led to price increases and reduced availability. Simultaneously, battery storage components are experiencing shortages, further delaying installations and complicating project timelines [^5].

🌤 The Long-Term Picture: A Resilient Future

Despite the headwinds, many in the industry see this as a short-term correction rather than a lasting decline. SEIA projects a return to 9% annual residential growth from 2025 to 2030, particularly if financing conditions improve and federal incentives remain intact [^1].

Additionally, solar panel prices remain historically low, hovering around $2.50–$2.60 per watt installed. That affordability, coupled with increasing demand for home electrification and EV charging solutions, makes rooftop solar an attractive long-term investment [^1].

In a recent industry survey, 78% of solar installers said they expect to sell as much or more in 2025 than they did in 2024 [^3]. And while the market is down in states like California, others—including Texas, Florida, and Arizona—are continuing to grow.

✅ Final Takeaway

Yes, residential solar is currently in a downturn. But it’s more of a recalibration than a collapse. Regulatory turbulence and financial pressures are squeezing the market, but the fundamentals—affordability, environmental benefits, and technological advancement—remain strong.

The future of residential solar will depend heavily on stable policy support, affordable financing, and continued innovation. If those stars align, the industry could see another boom in the latter half of the decade.

Advertisement
image 101376000 12222003

📚 Sources

[^1]: SEIA/Wood Mackenzie. U.S. Solar Market Insight Q1 2025.

https://www.seia.org/us-solar-market-insight

[^2]: BloombergNEF. 2025–2035 U.S. Solar Outlook.

[^3]: SolarReviews. 2025 Solar Industry Installer Sentiment Survey.

[^4]: Reuters. Senate committee’s changes to tax bill slam US solar stocks. [June 2025]

https://www.reuters.com/sustainability/climate-energy/senate-committees-changes-tax-bill-slam-us-solar-stocks-2025-06-16

[^5]: AP News. China dominates solar. Trump tariffs target China. For US solar industry, that means higher costs. [June 2025]

Advertisement
image 101376000 12222003

https://apnews.com/article/e0a764b42a6ba638a4201c5683f98a6b

STM Daily News is a vibrant news blog dedicated to sharing the brighter side of human experiences. Emphasizing positive, uplifting stories, the site focuses on delivering inspiring, informative, and well-researched content. With a commitment to accurate, fair, and responsible journalism, STM Daily News aims to foster a community of readers passionate about positive change and engaged in meaningful conversations. Join the movement and explore stories that celebrate the positive impacts shaping our world.

https://stmdailynews.com/

 


Discover more from Daily News

Subscribe to get the latest posts sent to your email.

Continue Reading

Trending